全文获取类型
收费全文 | 7630篇 |
免费 | 1301篇 |
国内免费 | 261篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 437篇 |
妇产科学 | 153篇 |
基础医学 | 746篇 |
口腔科学 | 72篇 |
临床医学 | 1620篇 |
内科学 | 1603篇 |
皮肤病学 | 190篇 |
神经病学 | 675篇 |
特种医学 | 210篇 |
外科学 | 1621篇 |
综合类 | 128篇 |
预防医学 | 548篇 |
眼科学 | 141篇 |
药学 | 360篇 |
中国医学 | 4篇 |
肿瘤学 | 576篇 |
出版年
2023年 | 158篇 |
2022年 | 75篇 |
2021年 | 190篇 |
2020年 | 229篇 |
2019年 | 134篇 |
2018年 | 309篇 |
2017年 | 217篇 |
2016年 | 267篇 |
2015年 | 234篇 |
2014年 | 346篇 |
2013年 | 445篇 |
2012年 | 306篇 |
2011年 | 312篇 |
2010年 | 298篇 |
2009年 | 378篇 |
2008年 | 359篇 |
2007年 | 336篇 |
2006年 | 394篇 |
2005年 | 342篇 |
2004年 | 304篇 |
2003年 | 245篇 |
2002年 | 262篇 |
2001年 | 277篇 |
2000年 | 246篇 |
1999年 | 195篇 |
1998年 | 127篇 |
1997年 | 121篇 |
1996年 | 119篇 |
1995年 | 112篇 |
1994年 | 66篇 |
1993年 | 57篇 |
1992年 | 143篇 |
1991年 | 137篇 |
1990年 | 114篇 |
1989年 | 118篇 |
1988年 | 104篇 |
1987年 | 94篇 |
1986年 | 79篇 |
1985年 | 72篇 |
1984年 | 74篇 |
1983年 | 56篇 |
1982年 | 39篇 |
1979年 | 56篇 |
1978年 | 49篇 |
1977年 | 39篇 |
1973年 | 37篇 |
1972年 | 32篇 |
1971年 | 39篇 |
1967年 | 31篇 |
1966年 | 32篇 |
排序方式: 共有9192条查询结果,搜索用时 15 毫秒
1.
Jamaal L. Benjamin MD PhD Rebecca Dennis DO Stacy White Jr MD David Munson MD Sudha A. Anupindi MD Maciej Piskunowicz MD Kassa Darge MD PhD Ami Gokli MD Misun Hwang MD 《Journal of ultrasound in medicine》2020,39(5):1031-1036
Bowel diseases of prematurity, including necrotizing enterocolitis, are dreaded ailments of neonates. Early diagnosis is difficult, with clinical and radiographic findings often inconclusive. We present a novel use of contrast-enhanced ultrasound in detection of pediatric bowel disease. Early identification of compromised blood flow or an at-risk bowel can be quantitatively detected and monitored. This ability has implications for guidance of emerging therapies, allowing targeting of inflammation. These findings represent an advancement in detection of bowel disease in neonates. 相似文献
2.
3.
4.
5.
6.
7.
Susanne G Warner Adnan A Alseidi Johnny Hong Timothy M Pawlik Rebecca M Minter 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(9):785-790
BackgroundHepatopancreatobiliary (HPB) surgery fellowship training has multiple paths. Prospective trainees and employers must understand the differences between training pathways. This study examines self-reported fellowship experiences and current scope of practice across three pathways.MethodsAn online survey was disseminated to 654 surgeons. These included active Americas Hepato-Pancreato-Biliary Association (AHPBA) members and recent graduates of HPB, transplant–HPB and HPB–heavy surgical oncology fellowships.ResultsA total of 416 (64%) surgeons responded. Most respondents were male (89%) and most were practising in an academic setting (83%). 290 (70%) respondents underwent formal fellowship training. Although fellowship experiences varied, current practice was largely similar. Minimally invasive surgery (MIS) and ultrasound were the most commonly identified areas of training deficiencies and were, respectively, cited as such by 47% and 34% of HPB-, 49% and 50% of transplant-, and 52% and 25% of surgical oncology-trained respondents. Non-HPB cases performed in current practice included gastrointestinal (GI) and general surgery cases (56% and 49%, respectively) for HPB-trained respondents, transplant and general surgery cases (87% and 21%, respectively) for transplant-trained respondents, and GI surgery and non-HPB surgical oncology cases (70% and 28%, respectively) for surgical oncology-trained respondents.ConclusionsFellowship training in HPB surgery varies by training pathway. Training in MIS and ultrasound is deficient in each pathway. The ultimate scope of non-transplant HPB practice appears similar across training pathways. Thus, training pathway choice is best guided by the training experience desired and non-HPB components of anticipated practice. 相似文献
8.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
9.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
10.